🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Veterans Affairs Medical Center - Birmingham
Start Date
1999-11-16
Trial ID
NCT00004125
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
1999-02
Trial ID
NCT00003953
The primary objective of this trial is to compare the rate of pathologicall...
Status
Completed
Location
German Breast Group
Start Date
TBD
Trial ID
NCT00793377
The primary objective of this trial is to determine the rate of pathologica...
Status
Completed
Location
Multiple Locations
Start Date
1998-04
Trial ID
NCT00543829
Treatments Being Tested
This study will evaluate the pharmacokinetics, efficacy, and safety of the ...
Status
Completed
Location
Peking University People's Hospital
Start Date
2020-02-05
Trial ID
NCT04024462
This study will assess the usefulness of a technique called complementary d...
Status
Completed
Location
National Naval Medical Center
Start Date
2000-06
Trial ID
NCT00005908
The main goal of the study is to abandon breast surgery in patients with br...
Status
Recruiting
Location
Petr Krivorotko
Start Date
2019-10-08
Trial ID
NCT04293796
Treatments Being Tested
This is a global Phase III, two-arm, open-label, multicenter, randomized st...
Status
Completed
Location
Maryland Oncology Hematology
Start Date
2018-06-14
Trial ID
NCT03493854